Live feed
Filing
SC 13G
SC 13G0001193125-19-309318·Bain Capital Life Sciences Fund, L.P.
Schedule 13G ownership disclosure
X4 PHARMACEUTICALS INC
Security class unavailable · CUSIP: 98420X103
Event date: 2019-11-29
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.9900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-19-309318
- Form type
- SC 13G
- Filer
- Bain Capital Life Sciences Fund, L.P.
- CIK
- CIK 1687968
- Filed
- Dec 09, 2019
- Reporting period
- Nov 29, 2019
- Description
- Schedule 13G beneficial ownership